Scholar Rock Holding Corp (SRRK) Unusual Options Activity Today

Checking SRRK unusual options activity helps you spot when traders are making outsized bets on Scholar Rock Holding Corp before the broader market catches on. Scholar Rock Holding Corp's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor SRRK unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching SRRK unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking SRRK unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and SRRK unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clinical trials for the treatment of spinal muscular atrophy; and SRK-181, which is in Phase 1 clinical trials for the treatment of cancers that are resistant to checkpoint inhibitor therapies, such as anti-PD-1 or anti-PD-L1 antibody therapies. It is also developing a pipeline of novel product candidates with potential to transform the lives of patients suffering from a range of serious diseases, including neuromuscular disorders, cancer, and fibrosis.

The company has a collaboration agreement with Gilead Sciences, Inc. to discover and develop specific inhibitors of transforming growth factor beta activation for the treatment of fibrotic diseases. Scholar Rock Holding Corporation was founded in 2012 and is headquartered in Cambridge, Massachusetts.

Catalysts rarely arrive without a footprint, and SRRK unusual options activity is often where that footprint shows up first. Our scanner tracks Scholar Rock Holding Corp's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at SRRK unusual options volume on the call side or chasing put sweeps, Scholar Rock Holding Corp's unusual options flow today is one click away, so put it on your radar before the headlines hit.